Irene Marco-Rius1,2, Alan J Wright3, De-En Hu3, Dragana Savic4,5, Jack J Miller4,6,5, Kerstin N Timm4, Damian Tyler4,5, Kevin M Brindle3, Arnaud Comment3,7. 1. Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. imarco@ibecbarcelona.eu. 2. Institute for Bioengineering of Catalonia, Barcelona, Spain. imarco@ibecbarcelona.eu. 3. Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. 4. Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK. 5. Oxford Centre for Clinical Magnetic Resonance Research, Radcliffe Division of Medicine, University of Oxford, Oxford, UK. 6. Clarendon Laboratory, Department of Physics, University of Oxford, Oxford, UK. 7. General Electric Healthcare, Chalfont St Giles, UK.
Abstract
OBJECTIVES: To enhance detection of the products of hyperpolarized [2-13C]dihydroxyacetone metabolism for assessment of three metabolic pathways in the liver in vivo. Hyperpolarized [2-13C]DHAc emerged as a promising substrate to follow gluconeogenesis, glycolysis and the glycerol pathways. However, the use of [2-13C]DHAc in vivo has not taken off because (i) the chemical shift range of [2-13C]DHAc and its metabolic products span over 144 ppm, and (ii) 1H decoupling is required to increase spectral resolution and sensitivity. While these issues are trivial for high-field vertical-bore NMR spectrometers, horizontal-bore small-animal MR scanners are seldom equipped for such experiments. METHODS: Real-time hepatic metabolism of three fed mice was probed by 1H-decoupled 13C-MR following injection of hyperpolarized [2-13C]DHAc. The spectra of [2-13C]DHAc and its metabolic products were acquired in a 7 T small-animal MR scanner using three purpose-designed spectral-spatial radiofrequency pulses that excited a spatial bandwidth of 8 mm with varying spectral bandwidths and central frequencies (chemical shifts). RESULTS: The metabolic products detected in vivo include glycerol 3-phosphate, glycerol, phosphoenolpyruvate, lactate, alanine, glyceraldehyde 3-phosphate and glucose 6-phosphate. The metabolite-to-substrate ratios were comparable to those reported previously in perfused liver. DISCUSSION: Three metabolic pathways can be probed simultaneously in the mouse liver in vivo, in real time, using hyperpolarized DHAc.
OBJECTIVES: To enhance detection of the products of hyperpolarized [2-13C]dihydroxyacetone metabolism for assessment of three metabolic pathways in the liver in vivo. Hyperpolarized [2-13C]DHAc emerged as a promising substrate to follow gluconeogenesis, glycolysis and the glycerol pathways. However, the use of [2-13C]DHAc in vivo has not taken off because (i) the chemical shift range of [2-13C]DHAc and its metabolic products span over 144 ppm, and (ii) 1H decoupling is required to increase spectral resolution and sensitivity. While these issues are trivial for high-field vertical-bore NMR spectrometers, horizontal-bore small-animal MR scanners are seldom equipped for such experiments. METHODS: Real-time hepatic metabolism of three fed mice was probed by 1H-decoupled 13C-MR following injection of hyperpolarized [2-13C]DHAc. The spectra of [2-13C]DHAc and its metabolic products were acquired in a 7 T small-animal MR scanner using three purpose-designed spectral-spatial radiofrequency pulses that excited a spatial bandwidth of 8 mm with varying spectral bandwidths and central frequencies (chemical shifts). RESULTS: The metabolic products detected in vivo include glycerol 3-phosphate, glycerol, phosphoenolpyruvate, lactate, alanine, glyceraldehyde 3-phosphate and glucose 6-phosphate. The metabolite-to-substrate ratios were comparable to those reported previously in perfused liver. DISCUSSION: Three metabolic pathways can be probed simultaneously in the mouse liver in vivo, in real time, using hyperpolarized DHAc.
Authors: Matthew E Merritt; Crystal Harrison; A Dean Sherry; Craig R Malloy; Shawn C Burgess Journal: Proc Natl Acad Sci U S A Date: 2011-11-07 Impact factor: 11.205
Authors: Hong Shang; Subramaniam Sukumar; Cornelius von Morze; Robert A Bok; Irene Marco-Rius; Adam Kerr; Galen D Reed; Eugene Milshteyn; Michael A Ohliger; John Kurhanewicz; Peder E Z Larson; John M Pauly; Daniel B Vigneron Journal: Magn Reson Med Date: 2016-10-21 Impact factor: 4.668
Authors: Karlos X Moreno; Santhosh Satapati; Ralph J DeBerardinis; Shawn C Burgess; Craig R Malloy; Matthew E Merritt Journal: J Biol Chem Date: 2014-10-28 Impact factor: 5.157
Authors: Alexander Kirpich; Mukundan Ragavan; James A Bankson; Lauren M McIntyre; Matthew E Merritt Journal: J Chem Inf Model Date: 2019-01-15 Impact factor: 4.956
Authors: Cornelius von Morze; Gene-Yuan Chang; Peder E Z Larson; Hong Shang; Prasanna K R Allu; Robert A Bok; Jason C Crane; Marram P Olson; Chou T Tan; Irene Marco-Rius; Sarah J Nelson; John Kurhanewicz; David Pearce; Daniel B Vigneron Journal: Magn Reson Med Date: 2016-04-21 Impact factor: 4.668
Authors: Michael Pavlides; Rajarshi Banerjee; Elizabeth M Tunnicliffe; Catherine Kelly; Jane Collier; Lai Mun Wang; Kenneth A Fleming; Jeremy F Cobbold; Matthew D Robson; Stefan Neubauer; Eleanor Barnes Journal: Liver Int Date: 2017-05-30 Impact factor: 5.828
Authors: Irene Marco-Rius; Tian Cheng; Adam P Gaunt; Saket Patel; Felix Kreis; Andrea Capozzi; Alan J Wright; Kevin M Brindle; Olivier Ouari; Arnaud Comment Journal: J Am Chem Soc Date: 2018-10-22 Impact factor: 15.419